About Us
NeoLacta Lifesciences has developed proprietary technology to offer nutritional solutions derived from 100% human milk that helps meet the unique requirements of premature babies in the NICU.
We are the only company in India and Asia to have developed 100% human milk products which address the needs of neonatal nutrition and thus play a critical role in supporting the “intact survival” of the premature babies.
Numerous clinical trials have proven the value of human milk products in saving the lives of premature babies (defined as any baby with a Gestational age < 37 weeks), low birth weight babies (< 2500g) and provide an alternative for low / non-lactating mothers.
This proprietary technology for processing of human milk was developed in Australia. The promoters of NeoLacta have supplied human milk pasteurizing and protein concentration equipment to Dr. Peter Hartmann, a well know authority who has been associated with the first breast milk bank called the PREM Milk bank at the King Edward Memorial Hospital, Perth, Western Australia.
Whilst a new product and concept in India, there are two companies that have been promoting such neonatal nutritional products in the United States (USA) over the last 15 years.
Our process complies with the key global guidelines from,
• IAP (Indian Academy of Pediatrics).
• AAP (American Academy of Pediatrics).
• HMBANA (Human Milk Banking Association of Noth America).
The benefits of pasteurized human milk are striking when compared to infant formula.
Human milk components in fresh mother’s milk after freezing and pasteurization Vs. formula and special formula
| Components | Expressed breast milk (EBM) | After freezing and pasteurization | Formula | Special Formula | Functions |
| IgA and SlgA | 100 | 67-70 | 0 | 0 | Infant’s do not produce SlgA until 6-9 months; active against Polio, Coxsackievirus, Herpes, CMV, RSV, Rubella, and Rotavirus. |
| IgM | 100 | 100 | 0 | 0 | Active against CMV, RSV, and Rubella. |
| IgG | 100 | 66-70 | 0 | 0 | Active against CMV, RSV, and Rubella. |
| Lactoferrin | 100 | 27-43 | 0 | 0 | The protein that binds iron required by many bacteria and thus slows bacterial growth. |
| Lysozyme | 100 | 75 | 0 | 0 | Enzymes that break bacterial cell walls, destroying them. |
| Lipases | 0 | 0 | 0 | 0 | Protect against “envelop viruses”. |
| Monoglycerides | 100 | 100 | 0 | 0 | Disrupts membrane coating of many viruses and protozoans destroying them. |
| Free fatty acids | 100 | 100 | Added to some formulas | – | Disrupts membrane coating of many viruses and protozoans destroying them. |
| Linoleic acid | 100 | 100 | Added to some formulas | – | Essential fatty acid; the metabolic precursor for prostaglandins and leukotrienes. |
| Alpha-linolenic acid | 100 | 100 | Added to some formulas | – | Essential fatty acid; metabolic precursor for docosahexaenoic acid; important for eye and brain development. |
| Bifidus factor | 100 | 70-100 | – | – | Promotes growth of Lactobacillus bifidus, a harmless bacterium to prevent the growth of harmful bacteria in the gut. |
| Oligosacc | 100 | 100 | – | – | Binds harmful bacteria. |
| Vitamin A | 100 | 100 | – | – | Protection against disease; gut mucosa sensitive to vitamin A. |
The table is adapted from Tully DB, Jones F and Tully MR. Donor milk; What’s in it and what’s not. J Hum Lact. 2001;17(2):152-155.
Become a Donor
Interested in donating your excess milk ?
Your donation can save the life of a premature baby.
We request you to kindly fill the form and we will get in touch with you.